Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

TB-4 Corneal Healing Results Timeline Expect: Comparison

Epithelial Migration 14–21 days (full closure) 7–14 days (full closure) Upregulates actin polymerization; increases lamellipodia formation by 50–60% Defect area reduction: 20–30% smaller at day 7 vs controls Faster symptom relief; reduced infection risk during

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Epithelial Migration
  • 14–21 days (full closure)
  • 7–14 days (full closure)
  • Upregulates actin polymerization; increases lamellipodia formation by 50–60%
  • Defect area reduction: 20–30% smaller at day 7 vs controls
  • Faster symptom relief; reduced infection risk during open wound phase
  • Basement Membrane Restoration
  • 3–4 weeks (hemidesmosome formation)
  • 2–3 weeks (hemidesmosome formation)
  • Promotes integrin expression; enhances cell-matrix adhesion
  • Hemidesmosome density: 1.8–2.2× higher at 4 weeks
  • Lower recurrent erosion rates (15–20% vs 35–40% in controls)
  • Stromal Remodeling
  • 8–16 weeks (collagen reorganization)
  • 8–12 weeks (collagen reorganization)
  • Modulates MMP activity; balances collagen synthesis and degradation
  • Stromal opacity: grade 0–1+ in superficial defects; grade 2–3+ in deep ulcers
  • Improved corneal clarity in non-penetrating injuries; variable results in deep stromal defects
  • Inflammatory Response
  • Peak IL-1β/TNF-α at 48–72 hours
  • Reduced IL-1β/TNF-α; maintained TGF-β signaling
  • Downregulates pro-inflammatory cytokines without suppressing growth factor production
  • Inflammatory cell infiltration: 30–40% reduction at day 3
  • Less discomfort; reduced risk of sterile infiltrates
  • Angiogenesis (in ischemic injuries)
  • Minimal neovascularization; delayed healing
  • Enhanced VEGF expression; controlled vessel ingrowth
  • Upregulates vascular endothelial growth factor in hypoxic tissue
  • Vessel density: 2–3× increase in limbal zone at 2 weeks
  • Supports healing in peripheral ulcers where blood supply is limited